Validation of noninvasive body-surface gastric mapping for detecting gastric slow-wave spatiotemporal features by simultaneous serosal mapping in porcine.
Stefan Calder, Leo K Cheng, Christopher N Andrews...
https://pubmed.ncbi.nlm.nih.gov/35916432/Actively Recruiting
Led by Central Hospital, Nancy, France · Updated on 2026-06-24
60
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating gastro-intestinal biopotentials using a homemade device with surface electrodes placed on the abdomen. The study includes healthy volunteers, Crohns disease patients both with and without fibrosis, and patients with functional gastrointestinal disorders FGID. It aims to determine if there are differences in biopotentials among these groups and how these biopotentials relate to clinical and imaging assessments like the Harvey-Bradshaw Index, MRI, and Rome IV criteria. Participants will undergo two recordings using the device the first lasting 1 hour and 30 minutes during a fasting state, followed by ingestion of a standardized meal, and a second 1 hour and 30 minute recording in the postprandial state. The device records gastro-intestinal bio-potentials non-invasively through surface electrodes placed on the abdomen. During the study, participants will have these two recording sessions along with evaluations correlating biopotential patterns to clinical scores, MRI results, and biological markers such as blood and fecal tests. The primary outcome is the pattern of gastro-intestinal biopotentials recorded over 12 months, with secondary outcomes assessing correlation with established clinical indices and biomarkers. The total study duration extends until 2027 with ongoing data collection and analysis.
CONDITIONS
Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Central Hospital, Nancy, France
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 3 hours on one day
Participants undergo two recording sessions with the device. The first session lasts 1 hour and 30 minutes during fasting. Then, after eating a standardized meal, a second session of 1 hour and 30 minutes is conducted in the postprandial state.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Stefan Calder, Leo K Cheng, Christopher N Andrews...
https://pubmed.ncbi.nlm.nih.gov/35916432/Ami D Sperber, Shrikant I Bangdiwala, Douglas A Drossman...
https://pubmed.ncbi.nlm.nih.gov/32294476/Giuseppe Riezzo, Francesco Russo, Flavia Indrio
https://pubmed.ncbi.nlm.nih.gov/23762836/Armen A Gharibans, Todd P Coleman, Hayat Mousa...
https://pubmed.ncbi.nlm.nih.gov/31009794/Jan D Huizinga, Wim J E P Lammers
https://pubmed.ncbi.nlm.nih.gov/18988693/Gabrio Bassotti, Elisabetta Antonelli, Vincenzo Villanacci...
https://pubmed.ncbi.nlm.nih.gov/24415856/Jonathan C Erickson, Laura E Bruce, Andrew Taylor...
https://pubmed.ncbi.nlm.nih.gov/31535980/Anne F Peery, Seth D Crockett, Caitlin C Murphy...
https://pubmed.ncbi.nlm.nih.gov/30315778/Saeed Alighaleh, Leo Cheng, Timothy R Angeli-Gordon...
https://pubmed.ncbi.nlm.nih.gov/33656985/Siew C Ng, Hai Yun Shi, Nima Hamidi...
https://pubmed.ncbi.nlm.nih.gov/29050646/Central Hospital, Nancy, France
Lead Sponsor